MedTrace Logo

Genetic Investigation of Cancer Predisposition

NCT04620278 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-01-06

No results posted yet for this study

Summary

Clinical information and samples (blood, saliva, and tumor) will be collected from patients with multiple cancers and/or a family history of cancer as well as from affected and unaffected relatives; samples will be systematically sequenced and evaluated for candidate driver mutations.

Conditions

  • Genetic Predisposition
  • Cancer

Interventions

GENETIC

DNA or RNA Sequencing

Samples will be used for whole exome (DNA) or RNA sequencing

Sponsors & Collaborators

  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Principal Investigators

  • Patricia L Dahia, MD, PhD · University of Texas Health at San Antonio

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-31
Primary Completion
2030-06-30
Completion
2035-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04620278 on ClinicalTrials.gov